Search
Saturday Sep 6 2008
All times are London time
All times are London time
The 6am cut - Alphaville by email
Most Popular Posts
- Further reading
- What killed the Ospraie?
- Draaisma: "We're in the dull phase"
- Further reading
- Cheap or spicy? - the polarisation in asset management
- Bank run
- Market "capitulation"
- Fear not, City of London
- The Chinese don't like Frannie...
- How do you value British banks?
- Show more...
- Show less...
Blogs we're reading
- 1440 Wall Street
- Abnormal Returns
- Alea
- All About Alpha
- Arbitrage View
- Bespoke Investment Group
- Big Picture
- Brad Setser: Follow the money
- Bronte Capital
- Calculated Risk
- Capital Chronicle
- Capitalist Resistance
- Credit Writedowns
- Crossing Wall Street
- Deal Journal
- Dealbook
- Dealbreaker
- Deus Ex Macchiato
- Felix Salmon
- Financial Armageddon
- Financial Crookery
- Fintag
- Free Exchange
- Infectious Greed
- Information Arbritrage
- Intelligent Mergers
- Interactive Investor
- Jeff Matthews
- Marketbeat
- Naked Capitalism
- Naked Shorts
- Nouriel Roubini
- Paul Wilmott
- Practical Risk Management
- Random Roger
- Reuters DealZone
- Robert Peston
- Short Stories
- Sudden Debt
- The Aleph blog
- The Epicurean Dealmaker
- The Oil Drum
- The price of everything
- Ultimi Barbarorum
- Wallstrip
Classified Jobs
- Director of Finance and Corporate Services
- Recruiter: NSPCC
- Head of Customer Service - Savings
- Recruiter: Nationwide Building Society
- Business Analyst
- Recruiter: Credit Suisse
- Head of Finance
- Recruiter: ESCP-EAP
- Group Chief Accountant
- Recruiter: Misys
- Lead Economist, Development Research Department
- Recruiter: African Development Bank
- Finance Manager
- Recruiter: London 2012
- Group Manufacturing Leadership Programme
- Recruiter: The Royal Bank of Scotland Group
Site Navigation
Principal content
Abert edwards AllianceBernstein allianz altria atticus babcock & brown bank of england barclays bill gross bill thompson blackstone british energy CALSTRS carlyle china development bank china merchants bank China Netcom commerzbank corus covered bonds cpdo Dollar Dresdner Bank ecb edf informa invesco Lehman Brothers M&G mohamed el-erian Moodys natixis Ospraie pimco providence RAB rbs rouble russia Spinco Tata Group tata steel telefonica UST Washington Mutual Wing Lung Bank
Australia’s Sigma eyes bid for Symbion
Australia’s Sigma Pharmaceuticals on Thursday emerged as a potential bidder for the pharmacy services and consumer businesses of domestic rival Symbion Health, potentially creating an obstacle to an agreed A$2.86bn bid for Symbion by Healthscope. Healthscope and its private equity partners, Ironbridge Capital and Archer Capital, have already received board approval for their Symbion bid in a deal that would create Australia’s largest hospital and diagnostics group. Under that deal Symbion would be split up between Healthscope and the private equity firms, which would take the pharmacy and consumer businesses.
- Advertise with the FT
- Press enquiries
- Student offers
- FT Conferences
- FT Research Centre
- Corporate subscriptions
- FT Group
- Partner sites: Chinese FT.com
- Les Echos
- FT Deutschland
- Expansion
- © Copyright The Financial Times Ltd 2007. "FT" and "Financial Times" are trademarks of The Financial Times Ltd. Privacy policy
- Terms
Comments
This post is closed to comments.